Abstract
Background: HbA1c is a widely used biomarker for the management of diabetes mellitus and can be quantified from blood samples by using various methods, including ion-exchange high-performance liquid chromatography (HPLC), boronate affinity HPLC, and capillary electrophoresis (CE). Here, we evaluated the accuracy of four separation methods for determination of HbA1c values in Chinese patients with different hemoglobin disorders.
Methods: Blood samples from normal patients, patients with β-thalassemia, patients exhibiting heterozygosity, and patients exhibiting homozygosity were analyzed using ion-exchange HPLC (Variant II Turbo, Bio-Rad and Adams A1c HA-8160, Arkray, run in diabetes mode), boronate affinity HPLC (Ultra2, Trinity Biotech), and CE (Capillarys 2 Flex Piercing, Sebia).
Results: Samples from patients with β-thalassemia produced significant positive biases on the Variant II Turbo system compared to the other three systems. For heterozygous βA/βE patients, a good agreement was observed between Capillarys 2 Flex Piercing and Ultra2 systems, while a significant negative bias was observed between HA-8160 and Capillarys 2 Flex Piercing systems and between Variant II Turbo and Capillarys 2 Flex Piercing systems. For homozygous (βE/βE) patients, a clear context without HbA, all systems except the Capillarys 2 Flex Piercing system yielded random HbA1c results. Only the Capillarys 2 Flex Piercing system could detect all hemoglobin variants tested.
Conclusions: β-Thalassemia can cause errors in HbA1c determination using the Variant II Turbo system. HbE heterozygosity or HbE homozygosity also complicated HbA1c measurements. The Capillarys 2 Flex Piercing system detected all Hb variants and HbA1c in patients with β-thalassemia and could provide measurements with high accuracy.
References
1. The Diabetes Control Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977–86.10.1056/NEJM199309303291401Search in Google Scholar
2. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS33). Lancet 1998;352:837–53.10.1016/S0140-6736(98)07019-6Search in Google Scholar
3. Sacks DB, Bruns DE, Goldstein DE, Maclaren NK, McDonald JM, Parrott M. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 2002;48:436–72.10.1093/clinchem/48.3.436Search in Google Scholar
4. Nathan DM, Balkau B, Bonora E, Borch-Johnsen K, Buse JB, Colagiuri S, et al. International Expert Committee report on the role of the A1c assay in the diagnosis of diabetes. Diabetes Care 2009;32:1327–34.10.2337/dc09-1777Search in Google Scholar
5. Sacks DB, Arnold M, Bakris GL, Bruns DE, Horvath AR, Kirkman MS, et al. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Diabetes Care 2011;34:e61–99.10.2337/dc11-9998Search in Google Scholar PubMed PubMed Central
6. Weykamp CW, John WG, Mosca A. A review of the challenge in measuring hemoglobin A1c. J Diabetes Sci Technol 2009;3:439–45.10.1177/193229680900300306Search in Google Scholar PubMed PubMed Central
7. Weykamp CW. HbA1c: a review of analytical and clinical aspects. Ann Lab Med 2013;33:393–400.10.3343/alm.2013.33.6.393Search in Google Scholar PubMed PubMed Central
8. Little RR, Rohlfing CL, Sacks DB. Status of hemoglobin A1c measurement and goals for improvement: from chaos to order for improving diabetes care. Clin Chem 2011;57:205–14.10.1373/clinchem.2010.148841Search in Google Scholar PubMed
9. Mosca A, Goodall I, Hoshino T, Jeppsson JO, John WG, Little RR, et al. Global standardization of glycated hemoglobin measurement: the position of the IFCC Working Group. Clin Chem Lab Med 2007;45:1077–80.10.1515/CCLM.2007.246Search in Google Scholar PubMed
10. Rhea JM, Koch D, Ritchie J, Singh HV, Young AN, Burgess T, et al. Unintended reporting of misleading HbA1c values when using assays incapable of detecting hemoglobin variants. Arch Pathol Lab Med 2013;137:1788–91.10.5858/arpa.2012-0714-OASearch in Google Scholar PubMed
11. Wiwanitkit V. Problem of using hemoglobin A1c measurement in endemic area of hemoglobinopathy. Prim Care Diabetes 2007;1:173–5.10.1016/j.pcd.2007.07.004Search in Google Scholar PubMed
12. Lee ST, Kim MS, Choi DY, Kim SK, Ki CS. Incidence of variant hemoglobin (Hb) and increased fetal Hb concentrations and their effect on HbA1c measurement in a Korean population. Clin Chem 2006;52:1445–6.10.1373/clinchem.2006.069617Search in Google Scholar PubMed
13. Schnedl WJ, Krause R, Piswanger-Soelkner C, Lipp RW. Effect of silent hemoglobin variants on A1c measurement with the IFCC reference method and 6 routine methods. Clin Chim Acta 2008;398:161–2.10.1016/j.cca.2008.08.008Search in Google Scholar PubMed
14. Little RR, Roberts W. A review of variant hemoglobins interfering with hemoglobin A1c measurement. J Diabetes Sci Technol 2009;3:446–51.10.1177/193229680900300307Search in Google Scholar PubMed PubMed Central
15. Zhu Y, Williams L. Falsely elevated hemoglobin A1c due to S-β+-thalassemia interference in Bio-Rad Variant II Turbo HbA1c assay. Clin Chim Acta 2009;40918–20.10.1016/j.cca.2009.08.009Search in Google Scholar PubMed
16. Little RR, Rohlfing CL, Hanson S, Connolly S, Higgins T, Weykamp CW, et al. Effects of hemoglobin HbE and HbD traits on measurements of glycated Hb (HbA1c) by 23 methods. Clin Chem 2008;54:1277–82.10.1373/clinchem.2008.103580Search in Google Scholar PubMed
17. Jaisson S, Leroy N, Desroches C, Tonye-Libyh M, Guillard E, Gillery P. Interference of the most frequent haemoglobin variants on quantification of HbA1c: comparison between the LC–MS (IFCC reference method) and three routinely used methods. Diabetes Metab 2013;39:363–9.10.1016/j.diabet.2013.01.004Search in Google Scholar PubMed
18. Prindle KH Jr, McCurdy PR. Red cell lifespan in hemoglobin C disorders (with special reference to hemoglobin C trait). Blood 1970;36:14–9.10.1182/blood.V36.1.14.14Search in Google Scholar
19. Polage C, Little RR, Rohlfing CL, Cole TG, Roberts WL. Effects of beta thalassemia minor on results of six glycohemoglobin methods. Clin Chim Acta 2004;350;123–8.10.1016/j.cccn.2004.07.015Search in Google Scholar PubMed
20. McCurdy PR. 32-DFP and 51-Cr for measurement of red cell life span in abnormal hemoglobin syndromes. Blood 1969;33:214–24.10.1182/blood.V33.2.214.214Search in Google Scholar
21. Gallo E, Pich P, Ricco G, Saglio G, Camaschella C, Mazza U. The relationship between anemia, fecal stercobilinogen, erythrocyte survival, and globin synthesis in heterozygotes for beta-thalassemia. Blood 1975;46:693–8.10.1182/blood.V46.5.693.693Search in Google Scholar
22. American Diabetes Association. Standards of Medical Care in Diabetes 2013. Diabetes Care 2013;36(Suppl 1):S11–66.10.2337/dc13-S011Search in Google Scholar PubMed PubMed Central
23. Chen W, Zhang X, Shang X, Cai R, Li L, Zhou T, et al. The molecular basis of beta-thalassemia intermedia in southern China: genotypic heterogeneity and phenotypic diversity. BMC Med Genet 2010;11:31.10.1186/1471-2350-11-31Search in Google Scholar PubMed PubMed Central
24. Stephens AD, Angastiniotis M, Baysal E, Chan V, Fucharoen F, Giordano PC, et al. ICSH recommendations for the measurement of HbA2. Int J Lab Hematol 2012;34:1–13.10.1111/j.1751-553X.2011.01368.xSearch in Google Scholar PubMed
25. Urrechaga E. High-resolution HbA1c separation and hemoglobinopathy detection with capillary electrophoresis. Am J Clin Pathol 2012;138:448–56.10.1309/AJCPVYW9QZ9EVFXISearch in Google Scholar PubMed
26. Little RR, Vesper H, Rohlfing CL, Ospina M, Safar-Pour S, Roberts WL. Validation by a mass spectrometric reference method of use of boronate affinity chromatography to measure glycohemoglobin in the presence of hemoglobin S and C traits. Clin Chem 2005;51:264–5.10.1373/clinchem.2004.043141Search in Google Scholar PubMed
27. Lin CN, Emery TJ, Little RR, Hanson SE, Rohlfing CL, Jaisson S, et al. Effects of hemoglobin C, D, E, and S traits on measurements of HbA1c by six methods. Clin Chim Acta 2012;413:819–21.10.1016/j.cca.2011.12.019Search in Google Scholar PubMed PubMed Central
28. Sthaneshwar P, Shanmugam H, Swan VG, Nasurdin N, Tanggaiah K. Effect of HbE heterozygosity on the measurement of HbA1c. Pathology 2013;45:417–9.10.1097/PAT.0b013e32836142ebSearch in Google Scholar PubMed
29. Jaisson S, Leroy N, Meurice J, Guillard E, Gillery P. First evaluation of Capillarys 2 Flex Piercing (Sebia) as a new analyzer for HbA1c assay by capillary electrophoresis. Clin Chem Lab Med 2012;50:1769–52.10.1515/cclm-2012-0017Search in Google Scholar PubMed
30. Marinova M, Altinier S, Caldini A, Passerini G, Pizzagalli G, Brogi M, et al. Multicenter evaluation of hemoglobin A1c assay on capillary electrophoresis. Clin Chim Acta 2013;424: 207–11.10.1016/j.cca.2013.06.014Search in Google Scholar PubMed
31. Weykamp CW, Waenink-Wieggers H, Kemna E, Siebelder C. HbA1c: performance of the Sebia Capillarys 2 Flex Piercing. Clin Chem Lab Med 2013;51:e129–31.10.1515/cclm-2012-0560Search in Google Scholar PubMed
32. Li HJ, Zhao XN, Qin F, Li HW, Li L, He XJ, et al. Abnormal hemoglobins in the Silk Road region of China. Hum Genet 1990;86:231–5.Search in Google Scholar
33. Blackwell RQ, Ro IH, Liu CS, Yang HJ, Wang CC, Huang JT. Hemoglobin variant found in Koreans, Chinese, and North American Indians: alpha-2 beta-2 22 Glu Ala. Am J Phys Anthropol 1969;30:389–91.10.1002/ajpa.1330300307Search in Google Scholar PubMed
34. Lee ST, Weykamp CW, Lee YW, Kim JW, Ki CS. Effects of 7 hemoglobin variants on the measurement of glycohemoglobin by 14 analytical methods. Clin Chem 2007;53:2202–5.10.1373/clinchem.2007.093963Search in Google Scholar PubMed
35. Erali M, Pounder JI, Woods GL, Petti CA, Wittwer CT. Incidence of variant hemoglobin (Hb) and increased fetal Hb concentrations and their effect on HbA1c measurement in a Korean Population. Clin Chem 2006;52:1445–6.10.1373/clinchem.2006.069617Search in Google Scholar PubMed
36. Rhea JM, Roberts-Wilson TK, Molinaro RJ. Impact of hemoglobin variants on HbA1c interpretation: do we assume too much? MLO Med Lab Obs 2012;44:8, 10, 12, 14.Search in Google Scholar
©2015 by De Gruyter
